Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast

In 1999, the National Surgical Adjuvant Breast and Bowel Project (NSABP)-B24 trial demonstrated that tamoxifen reduced relapse risk in women with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS) and radiotherapy (RT). In 2002, Allred's subgroup analysis showed that t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of oncology 2015-09, Vol.26 (9), p.1898-1903
Hauptverfasser:	Lo, A C, Truong, P T, Wai, E S, Nichol, A, Weir, L, Speers, C, Hayes, M M, Baliski, C, Tyldesley, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents, Hormonal - therapeutic use Breast Neoplasms - therapy Carcinoma, Intraductal, Noninfiltrating - therapy Chemoradiotherapy - methods Disease-Free Survival Female Humans Mastectomy, Segmental Middle Aged Neoplasm Recurrence, Local Tamoxifen - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!